1. Home
  2. USLM vs IMNM Comparison

USLM vs IMNM Comparison

Compare USLM & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

HOLD

Current Price

$113.69

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$21.98

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
IMNM
Founded
1948
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.6B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
USLM
IMNM
Price
$113.69
$21.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$138.00
$32.80
AVG Volume (30 Days)
125.7K
900.7K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
0.19%
N/A
EPS Growth
23.22
51.40
EPS
1.06
N/A
Revenue
$144,435,000.00
$6,941,000.00
Revenue This Year
$27.25
N/A
Revenue Next Year
$13.76
$1,127.34
P/E Ratio
$104.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$94.41
$7.96
52 Week High
$141.44
$27.65

Technical Indicators

Market Signals
Indicator
USLM
IMNM
Relative Strength Index (RSI) 53.40 49.13
Support Level $110.68 $19.28
Resistance Level $131.46 $23.25
Average True Range (ATR) 3.92 1.22
MACD 1.56 0.05
Stochastic Oscillator 96.24 56.39

Price Performance

Historical Comparison
USLM
IMNM

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: